Abstract: A class of bicyclic benzenoid aminoalkylene ether and thioether compounds exhibiting pharmacological activity, including anti-secretory and anti-ulcerogenic activity, pharmaceutical compositions comprising these compounds, and methods for the treatment of gastrointestinal hyperacidity and ulcerogenic disorders in mammals using said compositions.
Type:
Grant
Filed:
July 27, 1987
Date of Patent:
May 17, 1988
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
Donald E. Kuhla, Henry F. Campbell, William L. Studt
Abstract: A process for the preparation of a viscosity-stable antacid composition containing an alginic acid salt comprising reacting an antacid material with said salt at elevated temperatures to form a reaction product and recovering said reaction product in stabilized form.
Type:
Grant
Filed:
March 7, 1986
Date of Patent:
May 17, 1988
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
Joseph R. Luber, Kenneth M. Feld, Richard J. Harwood, Wayne M. Grim
Abstract: This invention relates to pyridone-pyridyl-imidazolyl and triazolyl compounds, including methods for increasing cardiac contractility, pharmaceutical compositions including the same and methods for the preparation thereof.
Type:
Grant
Filed:
July 15, 1986
Date of Patent:
May 10, 1988
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
William C. Faith, Henry F. Campbell, Donald E. Kuhla
Abstract: A class of benzocyclobutene aminoalkylene ether and thioether compounds exhibiting pharmacological activity, including anti-secretory and anti-ulcerogenic activity, pharmaceutical compositions comprising these compounds, and methods for the treatment of gastrointestinal hyperacidity and ulcerogenic disorders in mammals using said compositions.
Type:
Grant
Filed:
July 28, 1986
Date of Patent:
May 10, 1988
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
Donald E. Kuhla, Henry F. Campbell, William L. Studt
Abstract: A class of 3- and 5-amino thiatriazine compounds exhibiting pharmacological activity, including anti-ulcerogenic and gastrointestinal cytoprotective activity, pharmaceutical compositions comprising these compounds, and methods for the treatment of gastrointestinal hyperacidity and ulcerogenic disorders in mammals using said compositions.
Type:
Grant
Filed:
April 27, 1984
Date of Patent:
May 3, 1988
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
William L. Studt, Donald E. Kuhla, Henry F. Campbell, Stuart A. Dodson
Abstract: A method for the relief of pruritus comprising the administration of an effective antipruritic amount of a N-(trifluoromethylphenyl)anthranilic acid ester to an afflicted patient.
Type:
Grant
Filed:
March 11, 1986
Date of Patent:
March 29, 1988
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
Robert L. Procaccini, Kim D. Lamon, Nicholas S. Hagen
Abstract: A class of 3- and 5-amino thiatriazine compounds exhibiting pharmacological activity, including gastrointestinal anti-ulcerogenic and cytoprotective activity, pharmaceutical compositions comprising these compounds, and methods for the treatment of gastrointestinal hyperacidity and ulcerogenic disorders in mammals using said compositions.
Type:
Grant
Filed:
February 4, 1987
Date of Patent:
February 23, 1988
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
Donald E. Kuhla, Henry F. Campbell, William L. Studt, Stuart A. Dodson, Robert A. Galemmo, Jr., Pamela J. Durham
Abstract: A method for increasing cardiotonic contractility in humans or other animals using a class of benzodiazinonepryidazinone and hydroxy-pyrazolyl compounds and pharmaceutical compositions including the same.
Type:
Grant
Filed:
November 22, 1985
Date of Patent:
February 16, 1988
Assignee:
William H. Rorer, Inc.
Inventors:
Donald E. Kuhla, Henry F. Campbell, William L. Studt, William C. Faith, Bruce F. Molino
Abstract: A class of bicyclic benzo-oxy heterocyclic ether and thioether compounds exhibiting pharmacological activity, including anti-secretory and anti-ulcerogenic activity, pharmaceutical compositions comprising these compounds, and methods for the treatment of gastro-intestinal hyperacidity and ulcerogenic disorders in mammals using said compositions.
Type:
Grant
Filed:
March 3, 1987
Date of Patent:
February 2, 1988
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
Donald E. Kuhla, Henry F. Campbell, William L. Studt, Kent W. Neuenschwander
Abstract: Cardiotonic fused aromatic bicyclic ring substituted thiazole compounds and their salts, methods for increasing cardiac contractility in humans and other mammals by the use of said compounds, pharmaceutical compositions including said compounds and methods for compound preparation.
Type:
Grant
Filed:
December 18, 1984
Date of Patent:
January 26, 1988
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
Donald E. Kuhla, Henry F. Campbell, William L. Studt
Abstract: This invention relates to methods for the prophylactic and curative treatment of gastrointestinal and cardiovascular disorders and parasitic infections in humans and animals, using a class of hetrocyclic amidino substituted urea and thiourea compounds, a novel class of heterocyclic amidino substituted urea and thiourea compounds and pharmaceutical compositions and animal feed additives including the same.
Type:
Grant
Filed:
September 16, 1982
Date of Patent:
November 17, 1987
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
William L. Studt, Harry K. Zimmerman, Stuart A. Dodson
Abstract: A class of 3- and 5-amino thiatriazine compounds exhibiting pharmacological activity, including gastrointestinal anti-ulcerogenic and cytoprotective activity, pharmaceutical compositions comprising these compounds, and methods for the treatment of gastrointestinal hyperacidity and ulcerogenic disorders in mammals using said compositions.
Type:
Grant
Filed:
December 2, 1985
Date of Patent:
November 3, 1987
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
Donald E. Kuhla, Henry F. Campbell, William L. Studt, Stuart A. Dodson
Abstract: This invention relates to a method of lowering blood pressure in humans and mammals using 2,6-disubstituted phenyl amidinoureas in which the phenyl ring is additionally substituted by a hydroxy, alkoxy, aralkoxy, alkenyloxy, alkynyloxy, haloacyloxy, or acyloxy group and to novel 2,6-disubstituted phenyl amidinoureas which possess pharmaceutical properties, including blood pressure lowering activity.
Type:
Grant
Filed:
December 6, 1984
Date of Patent:
November 3, 1987
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
William L. Studt, Richard L. Riley, George H. Douglas
Abstract: A class of bicyclic benzenoid aminoalkylene ether and thioether compounds exhibiting pharmacological activity, including anti-secretory and anti-ulcerogenic activity, pharmaceutical compositions comprising these compounds, and methods for the treatment of gastrointestinal hyperacidity and ulcerogenic disorders in mammals using said compositions.
Type:
Grant
Filed:
May 23, 1986
Date of Patent:
October 13, 1987
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
Donald E. Kuhla, Henry F. Campbell, William L. Studt
Abstract: A mandrel for opening a tube of flexible banding material wherein the tube is delivered in flat ribbon-like form with creased side edges is disclosed. The mandrel is in the form of a tetrahedron with two sets of surfaces which are in the form of isosceles triangles with each set of faces inclining towards one another to form a common base. A pair of relatively yieldable, sharp-edged wedging elements are disposed on each common base. Biasing means bias the wedging elements outwardly to limit positions at the ends of the common bases. Use of the mandrel to open a tube of flexible, heat-shrinkable banding material and creasing the material at points displaced 90.degree. from the initial creases is disclosed.
Abstract: Process and composition for the topical treatment of acne which comprises as ingredients a peroxide of an organic acid and an erythromycin compound selected from the group consisting of erythromycin and its stearate and glucoheptonate derivatives and in which said peroxide is from one-half to thirty times, the weight of said erythromycin compound, and a suitable pharmaceutically acceptable carrier.
Abstract: A class of bicyclic benzenoid aminoalkylene ether and thioether compounds exhibiting pharmacological activity, including anti-secretory and anti-ulcerogenic activity, pharmaceutical compositions comprising these compounds, and methods for the treatment of gastrointestinal hyperacidity and ulcerogenic disorders in mammals using said compositions.
Type:
Grant
Filed:
November 12, 1986
Date of Patent:
September 8, 1987
Assignee:
Rorer Pharmaceutical Corporation
Inventors:
Donald E. Kuhla, Henry F. Campbell, William L. Studt